
Images are for product identification. Refer to the selected batch for packaging and availability.
Humalog Kwik Pen
Drug Formula unavailable
YOUR PURCHASE PRICE
Out of stockInclusive of all taxes
Choose your batch
0 offersNo batches are available at this hub. Choose another hub to check availability.
Sign in to order for your pharmacy.
Product information
- Manufacturer
- Eli Lilly And Company (india) Pvt. Ltd.
- Category
- Allopathy
- Composition
- Not provided
- Packaging
- 5 PEN
- Box / case pack
- 1 / —
Description
HUMALOG KWIKPEN by ELI LILLY AND COMPANY (INDIA) PVT. LTD.
Humalog KwikPen is a pre-filled disposable pen containing insulin lispro, a rapid-acting human insulin analog manufactured by Eli Lilly and Company (India) Pvt. Ltd. It is available in different strengths, commonly U-100 (100 units/mL) and U-200 (200 units/mL), designed for convenient self-administration of insulin.
-
Composition The primary active ingredient is insulin lispro (r-DNA origin). Other ingredients include m-cresol, glycerol, dibasic sodium phosphate 7 H2O, zinc oxide, and water for injection, with hydrochloric acid and/or sodium hydroxide used to adjust pH.
-
Uses Humalog KwikPen is indicated to improve glycemic control in both adult and pediatric patients with Type 1 and Type 2 diabetes mellitus. It is a fast-acting insulin that helps lower blood sugar levels after meals and can be used for the initial stabilization of diabetes.
-
Dosage and Administration The dosage of Humalog KwikPen is individualized based on the patient's requirements and determined by a physician. It should be administered by subcutaneous injection into the abdominal wall, thigh, upper arm, or buttocks, generally within 15 minutes before a meal or immediately after a meal. Injection sites should be rotated to reduce the risk of lipodystrophy. The KwikPen delivers doses in 1-unit increments, with the U-100 and U-200 pens typically delivering a maximum of 60 units per single injection. Humalog U-100 can also be administered via continuous subcutaneous infusion pumps or intravenously under medical supervision, but Humalog U-200 should not be administered intravenously or transferred from the KwikPen to a syringe.
-
Side Effects Common side effects include hypoglycemia (low blood sugar), injection site reactions (such as pain, redness, itching, or swelling), and lipodystrophy (thickening or pitting of skin at the injection site). Other possible mild side effects are rash, itching, swelling of feet or ankles, and weight gain. Serious side effects, though less common, can include severe hypoglycemia, severe allergic reactions, and hypokalemia (low potassium levels in the blood).
-
Precautions It is crucial never to share a Humalog KwikPen, cartridge, or syringe between patients to prevent the risk of blood-borne pathogen transmission. Patients should monitor blood glucose levels frequently, especially when changes to the insulin regimen are made. Accidental mix-ups between insulin products can occur, so patients must always check the insulin label before each injection. Humalog is contraindicated during episodes of hypoglycemia and in patients hypersensitive to insulin lispro or any excipients. Caution is advised with concomitant use of PPAR-gamma agonists, as it may lead to fluid retention and heart failure.
-
Storage Unopened Humalog KwikPens should be stored in a refrigerator between 2°C to 8°C (36°F to 46°F) and protected from light until the expiration date. Do not freeze Humalog, and discard if it has been frozen. Once opened or in use, the KwikPen can be stored at room temperature (below 30°C or 86°F) for up to 28 days. Do not return an opened pen to the refrigerator. Always discard the pen 28 days after its first use, even if some insulin remains. Needles should not be stored attached to the pen.
Frequently asked questions
Here are frequently asked questions about Humalog KwikPen, along with concise, accurate answers:
What is Humalog KwikPen used for?
Humalog (insulin lispro) KwikPen is a rapid-acting insulin used to improve glycemic control (blood sugar levels) in adults and children aged 3 years and older with diabetes mellitus (type 1 and type 2).
How does Humalog KwikPen work?
Humalog KwikPen contains insulin lispro, which is a rapid-acting man-made insulin analog. It works by helping your body turn the food you eat into energy and also helps store energy for later use. It starts working faster than some other types of insulin, typically within 15 minutes, and its effects last for about 2 to 5 hours, mimicking the body's natural insulin response around mealtimes.
What is the usual dosage for Humalog KwikPen?
The dosage of Humalog KwikPen is individualized and determined by your healthcare provider based on your specific needs, blood sugar levels, and lifestyle. It is typically administered by subcutaneous injection within 15 minutes before a meal or immediately after a meal. The KwikPen dials in 1 unit increments and can deliver a maximum dose of 60 units per injection for the U-100 and U-200 pens.
What are the possible side effects of Humalog KwikPen?
The most common side effect of Humalog KwikPen is hypoglycemia (low blood sugar), which can cause symptoms like dizziness, shakiness, or sweating. Other common side effects include injection site reactions (redness, swelling, itching, or pain at the injection site) and lipodystrophy (thickening or pitting of the skin at injection sites). Serious but less common side effects can include severe allergic reactions (anaphylaxis) and hypokalemia (low potassium levels).
Is Humalog KwikPen safe during pregnancy or breastfeeding?
Managing diabetes effectively during pregnancy is crucial for both the mother and baby. Rapid-acting insulins like Humalog can be taken during pregnancy and while breastfeeding. However, it's important to consult your doctor, as insulin dose adjustments may be necessary throughout pregnancy and during breastfeeding.
Can Humalog KwikPen be taken with other medications?
Humalog KwikPen can interact with various medications. Certain drugs, such as beta-blockers, clonidine, and guanethidine, may affect glucose metabolism and necessitate insulin dose adjustments. Thiazolidinediones (TZDs), when used with insulin, can cause fluid retention and may worsen heart failure. Always inform your healthcare provider about all prescription, over-the-counter medications, and supplements you are taking, as dose changes or additional precautions may be needed.
What precautions should be taken when using Humalog KwikPen?
It is critical to never share your Humalog KwikPen or needles with another person, even if the needle is changed, to prevent the risk of transmitting blood-borne pathogens. Always check the insulin label before each injection to avoid medication errors. Monitor your blood glucose levels closely as changes in your insulin regimen, diet, or activity can affect your insulin needs. Do not use Humalog if your blood sugar is too low (hypoglycemia) or if the insulin appears cloudy, colored, or has particles.
What happens if a dose of Humalog KwikPen is missed?
If you forget to take your dose before a meal, you can still take it immediately after you finish eating. If it has been more than one hour since you ate, it is generally recommended to wait until your next scheduled dose, rather than taking a late dose, to avoid the risk of hypoglycemia. Never double up on doses to make up for a missed one. Monitor your blood sugar levels more frequently if a dose is missed.
How should Humalog KwikPen be stored?
Unopened Humalog KwikPens should be stored in the refrigerator at 36°F to 46°F (2°C to 8°C) until the expiration date printed on the label. Do not freeze Humalog. Once opened or in-use, a Humalog KwikPen can be stored out of the refrigerator at room temperature (below 86°F or 30°C) for up to 28 days. Keep it away from direct heat and light.